The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | G | Genito urinary system and sex hormones | |
| 2 | G01 | Gynecological antiinfectives and antiseptics | |
| 3 | G01A | ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS | |
| 4 | G01AG | Triazole derivatives |
| Code | Title | |
|---|---|---|
| G01AG02 | Terconazole |
| Active Ingredient | Description | |
|---|---|---|
| Terconazole |
Terconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. The accumulation of 14 alpha-methyl sterols correlates with the subsequent loss of ergosterol in the fungal cell wall and may be responsible for the antifungal activity of terconazole. Terconazole is used for the local treatment of vulvovaginal candidiasis (moniliasis). |
